eISSN 2097-6046
ISSN 2096-7446
CN 10-1655/R
Responsible Institution:China Association for Science and Technology
Sponsor:Chinese Nursing Association
Critical Care Research

Nursing care of a patient with glycogen storage disease complicated with sepsis and cold agglutination phenomenon

  • PAN Yinzhi ,
  • YANG Minfei
Expand

Received date: 2024-03-19

  Online published: 2025-01-22

Abstract

To summarize the nursing experience of a patient with glycogen storage disease complicated with sepsis and cold agglutination phenomenon. Glycogen storage disease is a rare metabolic disorder,factors such as fever and infection can easily induce acute metabolic crisis,and the patient was accompanied by cold agglutination,its treatment and nursing were complicated. The key points of nursing care included blood sugar and nutrition management,acidosis correction,infection control,evidence-based target body temperature management,ensuring safe blood transfusion. After 8 days of active treatment and careful nursing care,the patient’s condition improved and she was discharged. After 6 months of follow-up,she returned to the hospital as scheduled,the recovery was good.

Cite this article

PAN Yinzhi , YANG Minfei . Nursing care of a patient with glycogen storage disease complicated with sepsis and cold agglutination phenomenon[J]. Chinese Journal of Emergency and Critical Care Nursing, 2025 , 6(2) : 201 -203 . DOI: 10.3761/j.issn.2096-7446.2025.02.012

References

[1] Kishnani PS, Austin SL, Abdenur JE, et al. Diagnosis and ma-nagement of glycogen storage disease type I:a practice gui-deline of the American College of Medical Genetics and Genomics[J]. Genet Med, 2014, 16(11):e1.
[2] Parikh NS, Ahlawat R. Glycogen storage disease type I[M]. Clearwater: StatPearls Publishing, 2022.
[3] Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis cam-paign:international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11):1181-1247.
[4] Derks TGJ, Rodriguez-Buritica DF, Ahmad A, et al. Glycogen storage disease type ia:current management options,burden and unmet needs[J]. Nutrients, 2021, 13(11):3828.
[5] Berentsen S, R?th A, Randen U, et al. Cold agglutinin disease:current challenges and future prospects[J]. J Blood Med, 2019, 10:93-103.
[6] Berentsen S. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia[J]. Front Immunol, 2020, 11:590.
[7] Pitoulias AG, Bakr NA, Kazemtash M, et al. Von gierke disease (glycogen storage disease type I) and life-threatening abdomi-nal aortic aneurysm:a case report of an extremely rare condi-tion[J]. Vasc Specialist Int, 2023, 39:14.
[8] 陈永兴, 梁黎黎, 王晓建, 等. 糖原累积病Ⅰa型的诊断治疗和预防专家共识[J]. 中国实用儿科杂志, 2022, 37(9):641-649.
  Chen YX, Liang LL, Wang XJ, et al. Expert consensus on the diagnosis,treatment and prevention of glycogen storage disease type Ⅰa[J]. Chin J Pract Pediatr, 2022, 37(9):641-649.
[9] Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospi-tal:a systematic review[J]. Scand J Trauma Resusc Emerg Med, 2011, 19:74.
[10] Berentsen S. Complement activation and inhibition in autoim-mune hemolytic anemia:focus on cold agglutinin disease[J]. Semin Hematol, 2018, 55(3):141-149.
[11] 李绮萍. 环境温度控制对冷凝集患者的输血影响[J]. 中国医药科学, 2017, 7(11):155-157,186.
  Li QP. Effect of environmental temperature controlling on blood transfusion of patients with cold agglutination[J]. China Med Pharm, 2017, 7(11):155-157,186.
Outlines

/